Iridex

IRIDEX Corporation is a worldwide leader in developing and manufacturing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation to treat glaucoma and retinal diseases. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions.

IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit www.iridex.com.

Select the following link to view International Distributors.